Death Panel Rejects Breast Cancer Patients’ Avastin Pleas
Health Friday, July 1st, 2011
By Neil W. McCabe, Human Events
In a sign of things to come, members of the Food and Drug Administration’s Oncologic Drugs Advisory Committee voted Wednesday to reject an appeal of its December 2010 recommendation that the FDA withdraw its sanction of Avastin for treatment of breast cancer.
The day before, in what now seems futile, advocates for the drug rallied at the FDA headquarters in Silver Spring, Md., with signs, chants and a folk singer.
Blocked by a team of Homeland Security police officers in combat uniforms, the nearly 100 pink-shirted protesters massed in front of the entrance to the agency’s campus demanding it continue to approve Avastin for metastasized breast cancer.
Standing face-to-face with the on-site commander of the police contingent, which included deputies, keeping the protesters from marching toward the looming edifice 100 yards away, Terrence Kalley, the leader of the protest, said into his bullhorn, “We will continue to obey the law.”
Because Kalley, whose wife, Arlene, is battling metastasized breast cancer, was a scheduled witness to speak to the FDA’s Oncologic Drugs Advisory Committee hearing on Avastin, he was allowed to proceed to the building, after he put down his bullhorn and sign.
Kalley said his mission is to convince the panel to recommend that the FDA continue to sanction the drug bevacizumab, the technical name of c, for the treatment of breast cancer.
To read more, visit: http://www.humanevents.com/article.php?id=44557
Short URL: https://reteaparty.com/?p=2383
